These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 1279967)

  • 1. A multicenter, randomized, controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis.
    Sternlieb JM; Aronchick CA; Retig JN; Dabezies M; Saunders F; Goosenberg E; Infantolino A; Ionna S; Maislin G; Wright SH
    Am J Gastroenterol; 1992 Nov; 87(11):1561-6. PubMed ID: 1279967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of octreotide-acetate in preventing pancreatitis-like changes following therapeutic endoscopic retrograde cholangiopancreatography.
    Duvnjak M; Supanc V; Simicević VN; Hrabar D; Troskot B; Smircić-Duvnjak L; Bekavac-Beslin M
    Acta Med Croatica; 1999; 53(3):115-8. PubMed ID: 10705631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: A multicenter, placebo-controlled, randomized clinical trial.
    Li ZS; Pan X; Zhang WJ; Gong B; Zhi FC; Guo XG; Li PM; Fan ZN; Sun WS; Shen YZ; Ma SR; Xie WF; Chen MH; Li YQ
    Am J Gastroenterol; 2007 Jan; 102(1):46-51. PubMed ID: 17266687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of octreotide on the prevention of acute pancreatitis and hyperamylasemia after diagnostic and therapeutic ERCP.
    Arvanitidis D; Hatzipanayiotis J; Koutsounopoulos G; Frangou E
    Hepatogastroenterology; 1998; 45(19):248-52. PubMed ID: 9496522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment with methylprednisolone to prevent ERCP-induced pancreatitis: a randomized, multicenter, placebo-controlled clinical trial.
    Dumot JA; Conwell DL; O'Connor JB; Ferguson DR; Vargo JJ; Barnes DS; Shay SS; Sterling MJ; Horth KS; Issa K; Ponsky JL; Zuccaro G
    Am J Gastroenterol; 1998 Jan; 93(1):61-5. PubMed ID: 9448176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twenty-four hour prophylaxis with increased dosage of octreotide reduces the incidence of post-ERCP pancreatitis.
    Thomopoulos KC; Pagoni NA; Vagenas KA; Margaritis VG; Theocharis GI; Nikolopoulou VN
    Gastrointest Endosc; 2006 Nov; 64(5):726-31. PubMed ID: 17055865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of a long-acting somatostatin analogue (octreotide) for prophylaxis of acute pancreatitis after endoscopic sphincterotomy.
    Arcidiacono R; Gambitta P; Rossi A; Grosso C; Bini M; Zanasi G
    Endoscopy; 1994 Nov; 26(9):715-8. PubMed ID: 7536155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for post-ERCP pancreatitis: a prospective multicenter study.
    Cheng CL; Sherman S; Watkins JL; Barnett J; Freeman M; Geenen J; Ryan M; Parker H; Frakes JT; Fogel EL; Silverman WB; Dua KS; Aliperti G; Yakshe P; Uzer M; Jones W; Goff J; Lazzell-Pannell L; Rashdan A; Temkit M; Lehman GA
    Am J Gastroenterol; 2006 Jan; 101(1):139-47. PubMed ID: 16405547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of recombinant platelet-activating factor acetylhydrolase for reducing the incidence and severity of post-ERCP acute pancreatitis.
    Sherman S; Alazmi WM; Lehman GA; Geenen JE; Chuttani R; Kozarek RA; Welch WD; Souza S; Pribble J;
    Gastrointest Endosc; 2009 Mar; 69(3 Pt 1):462-72. PubMed ID: 19231487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prophylactic effect of somatostatin on post-therapeutic endoscopic retrograde cholangiopancreatography pancreatitis: a randomized, multicenter controlled trial.
    Lee KT; Lee DH; Yoo BM
    Pancreas; 2008 Nov; 37(4):445-8. PubMed ID: 18953260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indomethacin may reduce the incidence and severity of acute pancreatitis after ERCP.
    Sotoudehmanesh R; Khatibian M; Kolahdoozan S; Ainechi S; Malboosbaf R; Nouraie M
    Am J Gastroenterol; 2007 May; 102(5):978-83. PubMed ID: 17355281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective randomized double-blind placebo-controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography-induced pancreatitis.
    Sudhindran S; Bromwich E; Edwards PR
    Br J Surg; 2001 Sep; 88(9):1178-82. PubMed ID: 11531863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of octreotide versus placebo in the prevention of post-ERCP pancreatitis.
    Kisli E; Baser M; Aydin M; Guler O
    Hepatogastroenterology; 2007; 54(73):250-3. PubMed ID: 17419271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy--Italian Group.
    Cavallini G; Tittobello A; Frulloni L; Masci E; Mariana A; Di Francesco V
    N Engl J Med; 1996 Sep; 335(13):919-23. PubMed ID: 8786777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous nitroglycerin for prevention of pancreatitis after therapeutic endoscopic retrograde cholangiography: a randomized, double-blind, placebo-controlled multicenter trial.
    Beauchant M; Ingrand P; Favriel JM; Dupuychaffray JP; Capony P; Moindrot H; Barthet M; Escourrou J; Plane C; Barrioz T; Lacoste L; Ingrand I
    Endoscopy; 2008 Aug; 40(8):631-6. PubMed ID: 18680075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of postprocedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: a randomized, controlled, multicenter study.
    Manes G; Ardizzone S; Lombardi G; Uomo G; Pieramico O; Porro GB
    Gastrointest Endosc; 2007 Jun; 65(7):982-7. PubMed ID: 17531632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double blind study of interleukin 10 for the prevention of ERCP-induced pancreatitis.
    Dumot JA; Conwell DL; Zuccaro G; Vargo JJ; Shay SS; Easley KA; Ponsky JL
    Am J Gastroenterol; 2001 Jul; 96(7):2098-102. PubMed ID: 11467638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention of post-ERCP acute pancreatitis with octreotide].
    Baldazzi G; Conti C; Spotti EG; Arisi GP; Scevola M; Gobetti F; Agliardi CM; Galasso P; Bonomi E; Bianchi F
    G Chir; 1994; 15(8-9):359-62. PubMed ID: 7803209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Octreotide in the prevention of pancreatic damage induced by endoscopic sphincterotomy.
    Hardt PD; Kress O; Fadgyas T; Doppl W; Schnell-Kretschmer H; Wüsten O; Klör HU
    Eur J Med Res; 2000 Apr; 5(4):165-70. PubMed ID: 10799351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled trial of pentoxifylline for the prevention of post-ERCP pancreatitis.
    Kapetanos D; Kokozidis G; Christodoulou D; Mistakidis K; Sigounas D; Dimakopoulos K; Kitis G; Tsianos EV
    Gastrointest Endosc; 2007 Sep; 66(3):513-8. PubMed ID: 17725940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.